Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Pompe

Showing results (31-40 of 61) with videos related to

Pageof 7
Sort By:
European Urology Focus|November 14, 2017
Assessment of Oncological Outcomes After Radical Prostatectomy According to Preoperative and Postoperative Cancer of the Prostate Risk Assessment Scores: Results from a Large, Two-center ExperienceSami-Ramzi Leyh-Bannurah, Paolo Dell'Oglio, Emanuele Zaffuto, et al.
International Urology and Nephrology|September 22, 2017
Survival of metastatic renal cell carcinoma patients continues to improve over time, even in targeted therapy eraMichele Marchioni, Marco Bandini, Raisa S Pompe, et al.
BJU International|September 24, 2017
The impact of lymph node dissection and positive lymph nodes on cancer-specific mortality in contemporary pT<sub>2-3</sub> non-metastatic renal cell carcinoma treated with radical nephrectomyMichele Marchioni, Marco Bandini, Raisa S Pompe, et al.
World Journal of Urology|August 30, 2017
Marital status and gender affect stage, tumor grade, treatment type and cancer specific mortality in T<sub>1-2</sub> N<sub>0</sub> M<sub>0</sub> renal cell carcinomaMichele Marchioni, Tristan Martel, Marco Bandini, et al.
Clinical Genitourinary Cancer|February 17, 2018
Adjuvant Therapies in Nonmetastatic Renal-Cell Carcinoma: A Review of the LiteratureMarco Bandini, Ariane Smith, Michele Marchioni, et al.
World Journal of Urology|July 12, 2018
Inverse stage migration patterns in North American patients undergoing local prostate cancer treatment: a contemporary population-based update in light of the 2012 USPSTF recommendationsSami-Ramzi Leyh-Bannurah, Pierre I Karakiewicz, Raisa S Pompe, et al.
Clinical Genitourinary Cancer|September 25, 2017
Comparison of 11 Active Surveillance Protocols in Contemporary European Men Treated With Radical ProstatectomySami-Ramzi Leyh-Bannurah, Pierre I Karakiewicz, Paolo Dell'Oglio, et al.
Urologic Oncology|February 6, 2017
Radical prostatectomy neutralizes obesity-driven risk of prostate cancer progressionJonas Schiffmann, Georg Salomon, Derya Tilki, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|April 1, 2018
The effect of age on cancer-specific mortality in patients with small renal masses: A population-based analysisMarco Bandini, Michele Marchioni, Raisa S Pompe, et al.
European Journal of Cancer (Oxford, England : 1990)|September 9, 2015
Intraventricular methotrexate as part of primary therapy for children with infant and/or metastatic medulloblastoma: Feasibility, acute toxicity and evidence for efficacyRaisa S Pompe, André O von Bueren, Martin Mynarek, et al.
Pageof 7

Showing results (31-40 of 61) with videos related to

Sort By:
Pageof 7
European Urology Focus|November 14, 2017
Assessment of Oncological Outcomes After Radical Prostatectomy According to Preoperative and Postoperative Cancer of the Prostate Risk Assessment Scores: Results from a Large, Two-center ExperienceSami-Ramzi Leyh-Bannurah, Paolo Dell'Oglio, Emanuele Zaffuto, et al.
International Urology and Nephrology|September 22, 2017
Survival of metastatic renal cell carcinoma patients continues to improve over time, even in targeted therapy eraMichele Marchioni, Marco Bandini, Raisa S Pompe, et al.
BJU International|September 24, 2017
The impact of lymph node dissection and positive lymph nodes on cancer-specific mortality in contemporary pT<sub>2-3</sub> non-metastatic renal cell carcinoma treated with radical nephrectomyMichele Marchioni, Marco Bandini, Raisa S Pompe, et al.
World Journal of Urology|August 30, 2017
Marital status and gender affect stage, tumor grade, treatment type and cancer specific mortality in T<sub>1-2</sub> N<sub>0</sub> M<sub>0</sub> renal cell carcinomaMichele Marchioni, Tristan Martel, Marco Bandini, et al.
Clinical Genitourinary Cancer|February 17, 2018
Adjuvant Therapies in Nonmetastatic Renal-Cell Carcinoma: A Review of the LiteratureMarco Bandini, Ariane Smith, Michele Marchioni, et al.
World Journal of Urology|July 12, 2018
Inverse stage migration patterns in North American patients undergoing local prostate cancer treatment: a contemporary population-based update in light of the 2012 USPSTF recommendationsSami-Ramzi Leyh-Bannurah, Pierre I Karakiewicz, Raisa S Pompe, et al.
Clinical Genitourinary Cancer|September 25, 2017
Comparison of 11 Active Surveillance Protocols in Contemporary European Men Treated With Radical ProstatectomySami-Ramzi Leyh-Bannurah, Pierre I Karakiewicz, Paolo Dell'Oglio, et al.
Urologic Oncology|February 6, 2017
Radical prostatectomy neutralizes obesity-driven risk of prostate cancer progressionJonas Schiffmann, Georg Salomon, Derya Tilki, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|April 1, 2018
The effect of age on cancer-specific mortality in patients with small renal masses: A population-based analysisMarco Bandini, Michele Marchioni, Raisa S Pompe, et al.
European Journal of Cancer (Oxford, England : 1990)|September 9, 2015
Intraventricular methotrexate as part of primary therapy for children with infant and/or metastatic medulloblastoma: Feasibility, acute toxicity and evidence for efficacyRaisa S Pompe, André O von Bueren, Martin Mynarek, et al.
Pageof 7